Prediction of Distant Recurrence Using EndoPredict Among Women with ER +, HER2 – Node-Positive and Node-Negative Breast Cancer Treated with Endocrine Therapy Only.

Filipits, M; Dubsky, P; Rudas, M; Greil, R; Balic, M; Bago-Horvath, Z; Singer, CF; Hlauschek, D; Brown, K; Bernhisel, R; Kronenwett, R; Lancaster, JM; Fitzal, F; Gnant, M.

Clin Cancer Res. 2019 Jul 1;25(13):3865-3872. doi: 10.1158/1078-0432.CCR-19-0376. Epub 2019 May 7.

https://pubmed.ncbi.nlm.nih.gov/31064782/